-
AACR Scientist↔Survivor Program: The Patient PerspectiveIn a sea of p-values and distribution curves, patient advocates and survivors at a scientific gathering remind researchers who is behind the numbers.
by Marci A. Landsmann
-
Patient Advocates Go to WashingtonPatient advocates meet amid an outcry about research funding cuts, participate in a meeting with FDA officials and visit Capitol Hill.
by Marci A. Landsmann
-
The Affordable Care Act and Cancer PatientsCancer survivors tell their stories and researchers take a broad view.
by Kevin McLaughlin
-
Forward Look
Inside the 21st Century Cures ActLegislation brings high hopes for cancer research.
by Stephen Ornes
-
Survivor Profile
Putting Her Armor OnAn acute myeloid leukemia survivor and former TV news reporter finds a new reason to help others improve their health.
by Jennifer Walker
-
Q&A
Rolling Up Her SleevesPrincess Dina Mired of Jordan will be the first Arab president of the Union for International Cancer Control.
by Sue Rochman
-
Get Involved
Outdoor HealingAn outdoor adventure camp benefits cancer survivors of all ages.
by Lindsey Konkel
-
Forward Look
The Impact of Rising Drug CostsHigher prices of oral medicines may affect financial well-being.
by Chris Palmer
-
Forward Look
World Cancer Day: Accelerating ProgressImage courtesy of the Union for International Cancer Control February 4 is World Cancer Day, an international effort to increase cancer awareness and education to reduce preventable cancer deaths. World Cancer Day 2017 marks the midpoint of a three-year campaign, “We Can. I Can.” The overarching goal has been to encourage everyone, everywhere—from government health organizations […]
by Sue Rochman
-
Screening Gets PersonalConflicting and changing cancer screening guidelines have led to uncertainty and controversy. Can screening recommendations tailored for groups or individuals enhance benefits and reduce harms?
by Kate Yandell
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
